Animal models for the study of Chlamydia trachomatis infections in the female genital infection

Drugs of Today

Volumn 42, Issue SUPPL. A, 2006, Pages 55-63

  Vanrompay, Daisy ^a   Lyons, J M ^b   Morre S A ^c  

^a GHENT UNIVERSITY   (Belgium)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY RESPONSE; BACTERIAL INFECTION; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE GENITAL TRACT INFECTION; HAPLOTYPE; HUMAN; IMMUNOPATHOLOGY; IN VITRO STUDY; LYMPH NODE; LYMPHOGRANULOMA VENEREUM; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PELVIC INFLAMMATORY DISEASE; SALPINGITIS; SEROTYPE; UTERINE CERVIX EPITHELIUM; VIRUS REPLICATION;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DISEASE MODELS, ANIMAL; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; MACACA NEMESTRINA; MICE; SWINE;

EID: 33645387489     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (43)

1. Thygeson, P., Mengert, W.F. The virus of inclusion conjunctivitis. Arch Ophthalmol 1936, 15: 377-410.
2. Ripa, K.T., Moller, B.R., Mardh, P.A., Freundt, E.A., Meisen, F. Experimental acute salpingitis in grivet monkeys provoked by Chlamydia trachomatis. Acta Pathol Microbiol Scand 1979, 87B: 65-70.
3. Johnson, A.P., Hetherington, C.M., Osborn, M.F., Thomas, B.J., Taylor-Robinson, D. Experimental infection of the marmoset genital tract with Chlamydia trachomatis. Br J Exp Pathol 1980, 61: 291-5.
4. Moller, B.R., Mardh, P.A. Experimental salpingitis in grivet monkeys by Chlamydia trachomatis. Modes of spread of infection to the fallopian tubes. Acta Pathol Microbiol Scand 1980, 888: 107-14.
5. Woodland, R.M., Johnson, A.P., Tuffrey, M. Animal models of chlamydial infection. Br Med Bull 1983, 39: 175-80.
6. Tuffrey, M., Taylor-Robinson, D. Progesterone as a key factor in the development of a mouse model for genital-tract infection with Chlamydia trachomatis. FEMS Microbiol Lett 1981, 12: 111-15.
7. Barron, A.L., White, H.J., Rank, R.G., Soloff, B.L., Moses, E.B. A new animal model for the study of Chlamydia trachomatis genital infections: Infection of mice with the agent of mouse pneumonitis. J Infect Dis 1981, 143: 63-6.
8. Patton, D.L., Halbert, S.A., Kuo, C.C., Wang, S.P., Holmes, K.K. Host response to primary Chlamydia trachomatis infection of the fallopian tube in pig-tailed monkeys. Fertil Steril 1983, 40(6): 829-40.
9. Vanrompay, D., Hoang, T.Q.T., De Vos, L. et al. Specific pathogen free pigs as an additional animal model for studying Chlamydia trachomatis genital infection. Infect Immun 2005 (in press).
10. Swenson, C.E., Schachter, J. Infertility as a consequence of chlamydial infection of the upper genital tract in female mice. Sex Transm Dis 1984, 11: 64-7.
11. Tuffrey, M., Falder, P., Gale, J., Quinn, R., Taylor-Robinson, D. Infertility in mice infected genitalty with a human strain of Chlamydia trachomatis. J Reprod Fertil 1986, 78: 251-60.
12. Ito, J.I., Harrison, H.R., Alexander, E.R., Billings, L.J. Establishment of genital tract infection in the CF-1 mouse by intravaginal inoculation of a human oculogenital isolate of Chlamydia trachomatis. J Infect Dis 1984, 150: 577-82.
13. de la Maza, L.M., Pal, S., Khamesipour, A., Peterson, E.M. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun 1994, 62: 2094-7.
14. Darville, T., Andrews, C.W., Laffoon, K.K., Shymasani, W., Kishen, L.R., Rank, R.G. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect Immun 1997, 65: 3065-73.
15. Ito, J.I., Lyons, J.M., Airo-Brown, L.P. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection. Infect Immun 1990, 58: 2021-3.
16. Morrison, R.P., Caldwell, H.D. Immunity to murine chlamydial genital infection. Infect Immun 2002, 70: 2741-51.
17. Stagg, A.J., Tuffrey, M., Woods, C., Wunderink, E., Knight, S.C. Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infect Immun 1998, 66: 3535-44.
18. Ito, J.I., Lyons, J.M. Role of gamma interferon in controlling murine chlamydial genital tract infection. Infect Immun 1999, 67: 5518-21.
19. Ramsey, K.H., DeWolfe, J.L., Salyer, R.D. Disease outcome subsequent to primary and secondary urogenital infection with murine or human biovars of Chlamydia trachomatis. Infect Immun 2000, 68: 7186-9.
20. Morré, S.A., Lyons, J.M., Ito, J.I. Jr. Murine models of Chlamydia trachomatis genital tract infection: Use of mouse pneumonitis strain versus human strains. Infect Immun 2000, 68: 7209-11.
21. Suchland, R.J., Rockey, D.D., Bannantine, J.P., Stamm, W.E. Isolates of Chlamydia trachomatis that occupy non-fusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect Immun 2000, 68: 360-7.
22. Morrison, RP. Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon. Infect Immun 2000, 68: 6038-40.
23. Belland, R.J., Scidmore, M.A., Crane, D.D. et al. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc Natl Acad Sci USA 2001, 98: 13984-9.
24. Lyons, J.M., Ito, J.I., Peña, A.S., Morré, S.A. Differences in the growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum (MoPn). J Clin Path 2005 (in press).
25. Morré, S.A., van den Brule, A.J., Rozendaal, L. et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS 2002, 13 (Suppl. 2): 12-18.
26. van Valkengoed, I.G., Morŕ, S.A., van den Brule, A.J., Meijer, C.J., Bouter, L.M., Boeke, A.J. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes - implications for cost-effectiveness analyses. Int J Epidemiol 2004, 33: 416-25.
27. Lyons, J.M., Morré, S.A., Airo-Brown, L.P., Pena, A.S., Ito, J.I. Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection (submitted).
28. Patton, D.L., Halbert, S.A., Kuo, C.C., Wang, S.P., Holmes, K.K. Host response to primary Chlamydia trachomatis infection of the fallopian tube in pig-tailed monkeys. Fertil Steril 1983, 40(6): 829-40.
29. Patton, D.L. Immunopathology and histopathology of experimental chlamydial salpingitis. Rev Infect Dis 1985, 7(6): 746-53.
30. Patton, D.L., Kuo, C.C., Wang, S.P. et al. Chlamydial infection of subcutaneous fimbrial transplants in cynomolgus and rhesus monkeys. J Infect Dis 1987, 155(2): 229-35.
31. Patton, D.L., Kuo, C.C., Wang, S.P., Halbert, S.A. Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig-tailed macaques. J Infect Dis 1987, 155(6): 1292-9.
32. Wolner-Hanssen, P., Patton, D.L., Holmes, K.K. Protective immunity in pig-tailed macaques after cervical infection with Chlamydia trachomatis. Sex Transm Dis 1991, 18(1): 21-5.
33. Patton, D.L., Sweeney, Y.T., Kuo, C.C. Demonstration of delayed hypersensitivity in Chlamydia trachomatis salpingitis in monkeys: A pathogenic mechanism of tubal damage. J Infect Dis 1994, 169(3): 680-3.
34. Lichtenwalner, A.B., Patton, D.L., Van Voorhis, W.C., Sweeney, Y.T., Kuo, C.C. Heat shock protein 60 is the major antigen which stimulates delayed-type hypersensitivity reaction in the macaque model of Chlamydia trachomatis salpingitis. Infect Immun 2004, 72(2): 1159-61.
35. Lichtenwalner, A.B., Patton, D.L., Cosgrove Sweeney, Y.T., Gaur, L.K., Stamm, W.E. Evidence of genetic susceptibility to Chlamydia trachomatis-induced pelvic inflammatory disease in the pig-tailed macaque. Infect Immun 1997, 65(6): 2250-3.
36. Tuggle, C.K., Green, J.A., Fitzsimmons, C. et al. EST-based gene discovery in pig: Virtual expression patterns and comparative mapping to human. Mamm Genome 2003, 14(8): 565-79.
37. Lyons, J.M., Ito, J.I., Morré, S.A. Chlamydia trachomatis serovar E isolates from patients with different clinical manifestations have similar courses of infection in a murine model: Host factors as major determinants of C. trachomatis mediated pathogenesis. J Clin Pathol 2004, 57(6): 657-9.
38. Eckert, L.O., Hawes, S.E., Wolner-Hanssen, P.K. Endometritis: The clinical-pathologic syndrome. Am J Obstet Gynecol 2002, 186(4), 690-5.
39. Faro, S. Chlamydia trachomatis. In: Faro, S., Soper, D.E. (Eds.). Infectious Diseases in Women. W.B. Saunders Company: Philadelphia 2001, 451-67.
40. Møller, B.R., Weström, L., Ahrons, S. et al. Chlamydia trachomatis infection of the fallopian tubes. Histological findings in two patients. Br J Vener Dis 1979, 55: 422-8.
41. Rank, R.G., Sanders, M.M. Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection. Am J Pathol 1992, 140: 927-36.
42. Igietseme, J.U., Black, C.M., Caldwell, H.D. Chlamydia vaccines - Strategies and status. Bio Drugs 2002, 16: 19-35.
43. Kozlowski, P.A., Neutra, M.R., Flanigan, T.P., Cu-Uvin, S. Induction of antibodies in women after vaginal immunization during the mid-proliferative or mid-secretory phase of the menstrual cycle. Faseb J 2000, 14(6) (Suppl. S): A1248.